BillionToOne Inc (BLLN)

Currency in USD
84.32
-3.62(-4.12%)
Real-time Data·
BLLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
84.3189.63
52 wk Range
61.96138.70
Key Statistics
Prev. Close
87.94
Open
86
Day's Range
84.31-89.63
52 wk Range
61.96-138.7
Volume
97.56K
Average Volume (3m)
452.74K
1-Year Change
-
Book Value / Share
11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
117.71
Upside
+39.60%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

BillionToOne Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

6 Buy
2 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 117.71
(+39.60% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Guggenheim
Buy120.00+41.91%100.00Maintain13-05-2026
JPMorgan
Buy125.00+47.82%120.00Maintain07-05-2026
BTIG
Buy140.00+65.56%130.00Maintain06-05-2026
Guggenheim
Buy100.00+18.26%120.00Maintain30-03-2026
Piper Sandler
Buy130.00+53.74%-Maintain16-03-2026

BillionToOne Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue surged 84% YoY to $108.4M; EPS of $0.34 beat estimates, reversing prior year's $0.39 loss; stock jumped 16.27% after-hours.
  • Company achieved profitability with $18.0M net income and 73% gross margin, versus $4.0M loss in Q1 2025; operating income reached $17.8M.
  • Launched UNITY Confirm prenatal product in Q1; prenatal segment grew 72% while oncology revenue increased nearly fivefold year-over-year.
  • Management projects Q3 2026 EPS of $0.30 and revenue of $117.8M; Q4 2026 EPS forecast at $0.31, signaling continued growth trajectory.
  • Executives cite innovation and operational excellence as growth drivers; identified competition, regulatory delays, and supply chain risks as challenges.
Last Updated: 12-05-2026, 05:46 pm
Read Full Transcript

Earnings

Latest Release
06-05-2026
EPS / Forecast
0.34 / --
Revenue / Forecast
108.39M / --
EPS Revisions
Last 90 days

BLLN Income Statement

Compare BLLN to Peers and Sector

Metrics to compare
BLLN
Peers
Sector
Relationship
P/E Ratio
167.5x3.8x−0.5x
PEG Ratio
1.34−0.190.00
Price/Book
8.2x1.6x2.6x
Price / LTM Sales
11.8x0.8x3.2x
Upside (Analyst Target)
36.5%55.9%50.4%
Fair Value Upside
Unlock38.8%7.2%Unlock

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.34M7.26%293.76M
Other Institutional Investors
34.30M74.57%3.02B
Public Companies & Retail Investors
8.35M18.16%734.64M
Total
45.99M100.00%4.04B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Baillie Gifford US Growth Trust PLC0.90%4,15,48336,538
Adams Street Private Equity Navigator Fund0.54%2,46,93921,716

FAQ

What Is the BillionToOne (BLLN) Share Price Today?

The BillionToOne share price today is 84.32.

What is the current BillionToOne (BLLN) share price and day range?

As of 15-05-2026, the BillionToOne share price is 84.32, with a previous close of 87.94. The share price has ranged from 84.31 to 89.63 today, while the 52-week range spans from 61.96 to 138.70.

What Is the BillionToOne Market Cap?

As of today, BillionToOne market cap is 4.04B.

What Is the BillionToOne (BLLN) Share Price Target?

The average 12-month share price target for BillionToOne is 117.71, with a high estimate of 145 and a low estimate of 90. 6 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +39.60% Upside potential.

What Is BillionToOne's Earnings Per Share (TTM)?

The BillionToOne EPS (TTM) is 1.00.

When Is the Next BillionToOne Earnings Date?

BillionToOne will release its next earnings report on 06-05-2026.

From a Technical Analysis Perspective, Is BLLN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

What Stock Exchange Does BillionToOne Trade On?

BillionToOne is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for BillionToOne?

The stock symbol for BillionToOne is "BLLN."

How Many Times Has BillionToOne Stock Split?

BillionToOne has split 0 times.

How Many Employees Does BillionToOne Have?

BillionToOne has 713 employees.

What Is the BLLN Premarket Price?

BLLN's last pre-market stock price is 89.65. The pre-market share volume is 6,680.00, and the stock has changed by 1.71, or 1.94%.

What Is the BLLN After Hours Price?

BLLN's last after hours stock price is 89.15, the stock has changed by 1.21, or 1.38%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.